Search Results

Phylogenetic comparison of GPCRs in D. celebensis to those in humans (Homo sapiens), fruitfly (Drosophila Our findings suggest sporadic evolutionary processes within the GPCR gene families identified in D. celebensis

Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100 Sosei Heptares to Host R&D Day Highlighting its Innovative R&D and Late-Stage Development Progress Parker Moss to Join Exscientia

Innovation in the pharmaceutical industry: New estimates of R&D costs. Lu S, He X, Ni D, Zhang J. Persechino M, Hedderich JB, Kolb P, Hilger D. Dave K, Gelman H, Thu CT, Guin D, Gruebele M. Rößler P, Mayer D, Tsai CJ, Veprintsev DB, Schertler GFX, Gossert AD.

Schelshorn, D., et al., Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 Wootten, D., et al., Allostery and Biased Agonism at Class B G Protein-Coupled Receptors.  

Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases Sosei Heptares Enters R&D Treating Type 2 Diabetes and Obesity Special report 2022: Meet 20 women blazing trails in biopharma R&D

Medel-Lacruz, B., Baidya, M., Makarova, M., Mistry, R., Goulding, J., Drube, J., Hoffmann, C., Owen, D. J., & Calebiro, D. (2023). 2255.e20. https://doi.org/10.1016/j.cell.2023.04.018 Janetzko, J., Kise, R., Barsi-Rhyne, B., Siepe, D.

Comparative evaluation of biased agonists Sarcosine1 , d-Alanine8 -Angiotensin (Ang) II (SD Ang II) and GPCRs in Oncology and Immunology LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine , impairs growth of patient-derived xenografts of colorectal carcinoma in mice.

from September 30th to October 6th, 2024 Industry News Nxera Pharma appoints experienced commercial R&D executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan Septerna files for in Cardiology, Endocrinology, and Taste Ciliary localization of GPR75 promotes fat accumulation in mice

Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled Receptor D However, involvement of the human Mas-related G-protein coupled receptor D (MRGPRD) in the regulation

Devki D Sukhtankar and Pina M Cardarelli's research: Burixafor Hydrobromide (GPC-100) effects on hematopoietic cells in mice and humans Mark your calendar! Novel C-X-C Chemokine Receptor 4 Antagonist and Mobilizer of Hematopoietic Stem/Progenitor Cells, in Mice

. -11.6 placebo, p<0.0001) at Week 5 (Cohen’s d effect size of 0.61).

Matt Barnes appointed President of Heptares Therapeutics Ltd., and Head of UK R&D Tokyo, Japan and Cambridge

adenocarcinoma: p = 0.004, mesothelioma: p = 0.039, ovarian serous cystadenocarcinoma: p = 0.048); (d)

Jurado, S., D. Goswami, Y. Zhang, A.J.M. Molina, T.C. Südhof, and R.C. Malenka. 2013. SNARE function analyzed in synaptobrevin/VAMP knockout mice. Science. 294:1117–1122. 5.

Cannabinoid Tolerance in S426A/S430A x β-Arrestin 2 Knockout Double-Mutant Mice. Deficiency of G protein-coupled receptor Gpr111/Adgrf2 causes enamel hypomineralization in mice by alteration Statins inhibit protein kinase D (PKD) activation in intestinal cells and prevent PKD1-induced growth Financial Year ended 31 December 2022 Addex Raises $5.0 Million in Equity Financing Testing the limits of SMILES-based

Parkinson’s Disease: A Mini-Review of Clinical Pharmacology. 2006 . (4)         Garcia-Borreguero, D. 2018 , 839 , 40–46. https://doi.org/10.1016/j.ejphar.2018.09.008 . (8)         Rinken, A.; Lavogina, D. D.; Hanada, K.; Pagano, R. E.; Miller, L. J. -J.; Kopanchuk, S.; Laasfeld, T.; Weinhart, M.; Schollmeyer, D.; Betschart, M.

Highlights: • The Foundry Arrives : R&D meets biotech with real-world acceleration, strategic consulting

endosomes and other organelles. eLife. 2024 Nov 8; 13:RP97033. doi: 10.7554/eLife.97033.3   Maurel D,

one sustained curiosity thread involved a protein released by alpha cells in the pancreas: Vitamin D

Career opportunities:  Senior Scientist, Phage Display | Manager, CMC Management | Translational R&D

Miranda-Pastoriza D, Bernárdez R, Azuaje J, Prieto-Díaz R, Majellaro M, Tamhankar AV, Koenekoop L, González

is strategic, method-proven insight for discovery teams, pharmacologists refining core skills, and R&D

Knockout studies in mice suggest that β-arrestin isoforms possess some level of functional redundancy , as depleting one isoform results leads to relatively mild effects (Conner, D.

Hilger, D., et al., Structural insights into differences in G protein activation by family A and family

startup environments Read Maria Majellaro's Full Recap ➤ Lab Leadership Without Ego: A Model for R&D

mechanosensing   GPCR Activation and Signaling A gain of function variant in RGS18 candidate for a familial mild Gi-GPCR signaling corrects compulsive-like grooming and anxiety-related behaviors in Sapap3 knockout mice

For Hodson, that moment came with a protein he’d been tracking for a decade: vitamin D binding protein

GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr.

do: bring four decades of frontline discovery insight straight to discovery-phase scientists and R&D

Every R&D team is under the same pressure: deliver validated targets, clean pharmacology, and translatable